INT288812

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.45
First Reported 2009
Last Reported 2009
Negated 0
Speculated 3
Reported most in Body
Documents 1
Total Number 3
Disease Relevance 3.41
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

intracellular (Vav1)
Vav1 (Mus musculus)
Pain Link Frequency Relevance Heat
cytokine 3 5.00 Very Low Very Low Very Low
Pain 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 195 99.28 Very High Very High Very High
Leukemia 63 98.12 Very High Very High Very High
Lymphatic System Cancer 132 97.72 Very High Very High Very High
Htlv Types I And Ii 3 86.60 High High
Chronic Lymphoid Leukemia 12 85.24 High High
Multiple Myeloma 3 79.88 Quite High
Targeted Disruption 3 50.00 Quite Low
Hematologic Neoplasms 3 28.60 Quite Low
Sprains And Strains 15 20.04 Low Low
Precursor Cell Lymphoblastic Leukemia-lymphoma 18 20.00 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
To this end, we first used a standard bioinformatics comparison tool available in that database to investigate whether the expression of VAV1 and/or RASGRF2 genes was deregulated in hematopoietic tumor cells relative to their normal cell counterparts.
Spec (whether) Regulation (deregulated) of Gene_expression (expression) of VAV1 associated with cancer
1) Confidence 0.45 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2788417 Disease Relevance 1.15 Pain Relevance 0
We next analyzed whether the expression levels of VAV1 and RASGRF2 genes were significantly altered in specific subgroups of patients affected of leukemia, lymphoma or myeloma.
Spec (whether) Regulation (altered) of Spec (whether) Gene_expression (expression) of VAV1 associated with leukemia and lymphatic system cancer
2) Confidence 0.45 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2788417 Disease Relevance 1.13 Pain Relevance 0
We next analyzed whether the expression levels of VAV1 and RASGRF2 genes were significantly altered in specific subgroups of patients affected of leukemia, lymphoma or myeloma.
Spec (whether) Regulation (altered) of Gene_expression (levels) of VAV1 associated with leukemia and lymphatic system cancer
3) Confidence 0.45 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2788417 Disease Relevance 1.13 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox